• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常卵巢细胞与衍生肿瘤之间分化标志物表达的变化。

Changes in expression of differentiation markers between normal ovarian cells and derived tumors.

作者信息

Van Niekerk C C, Ramaekers F C, Hanselaar A G, Aldeweireldt J, Poels L G

机构信息

Department of Cell Biology and Histology, Faculty of Medical Sciences, University of Nijmegen, The Netherlands.

出版信息

Am J Pathol. 1993 Jan;142(1):157-77.

PMID:7678716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1886830/
Abstract

The marker profile of 18 samples of normal human ovarian tissues and 138 samples of their derived tumors was established using 51 monoclonal antibodies directed against intermediate filaments, ovarian carcinoma-specific antigens, general tumor-associated antigens and MHC-I/II antigens. Our data show that vimentin and keratins 7, 8, 18, and 19 were found in both epithelial and some nonepithelial ovarian tumors. Several tumor samples contained additional keratins 4, 10, 13, and 14, as well as desmin. BW 495/36 and to a lesser extent HMFG-2 were usually found in all ovarian tumors that contained simple epithelial keratins, except the absence of HMFG-2 in gonadal tumors as well as in dysgerminomas. In contrast to the keratin antibodies, these two panepithelial antibodies were negative in normal mesothelial cells and granulosa cells of the ovarian follicles. In general, the marker TAG-72 appeared useful for its discrimination between positively stained mucinous adenomas, the ovarian carcinomas as well as germ cell tumors, and the negatively stained gonadal tumors, serous adenomas, and cystomas. OV632 appeared useful in the distinction between negatively stained serous adenomas and positively stained serous carcinomas. In contrast, the monoclonal antibodies OC 125, OV-TL 3, OV-TL 16, and MOv 18 can be considered as pan-ovarian carcinoma markers, however without the discriminative capability as seen for OV632. These ovarian carcinoma-associated antigens were hardly found expressed in gonadal and germ cell tumors, except in the group of endodermal sinus tumors. HLA-I was found to be expressed in almost all nucleated cells, although loss of HLA-I expression was seen in areas of tumor cells. HLA-DR was negative in normal ovarian tissue, but heterogeneous expression was noticed in most of the epithelial tumors.

摘要

使用51种针对中间丝、卵巢癌特异性抗原、一般肿瘤相关抗原以及MHC-I/II抗原的单克隆抗体,建立了18例正常人卵巢组织样本及其138例衍生肿瘤样本的标志物谱。我们的数据表明,波形蛋白以及角蛋白7、8、18和19在上皮性和一些非上皮性卵巢肿瘤中均有发现。一些肿瘤样本还含有额外的角蛋白4、10、13和14以及结蛋白。BW 495/36以及程度稍轻的HMFG-2通常在所有含有简单上皮角蛋白的卵巢肿瘤中被发现,除了性腺肿瘤以及无性细胞瘤中不存在HMFG-2。与角蛋白抗体相反,这两种全上皮抗体在正常间皮细胞和卵巢卵泡的颗粒细胞中呈阴性。总体而言,标志物TAG-72有助于区分阳性染色的黏液性腺瘤、卵巢癌以及生殖细胞肿瘤与阴性染色的性腺肿瘤、浆液性腺瘤和囊腺瘤。OV632有助于区分阴性染色的浆液性腺瘤和阳性染色的浆液性癌。相比之下,单克隆抗体OC 125、OV-TL 3、OV-TL 16和MOv 18可被视为全卵巢癌标志物,然而不像OV632那样具有鉴别能力。这些卵巢癌相关抗原在性腺和生殖细胞肿瘤中几乎未发现表达,除了内胚窦瘤组。HLA-I在几乎所有有核细胞中均有表达,尽管在肿瘤细胞区域可见HLA-I表达缺失。HLA-DR在正常卵巢组织中呈阴性,但在大多数上皮性肿瘤中观察到异质性表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1062/1886830/5f460df27aa2/amjpathol00073-0170-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1062/1886830/2e86480d06fd/amjpathol00073-0162-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1062/1886830/383cd88c2be1/amjpathol00073-0163-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1062/1886830/420656100024/amjpathol00073-0167-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1062/1886830/5f460df27aa2/amjpathol00073-0170-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1062/1886830/2e86480d06fd/amjpathol00073-0162-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1062/1886830/383cd88c2be1/amjpathol00073-0163-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1062/1886830/420656100024/amjpathol00073-0167-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1062/1886830/5f460df27aa2/amjpathol00073-0170-a.jpg

相似文献

1
Changes in expression of differentiation markers between normal ovarian cells and derived tumors.正常卵巢细胞与衍生肿瘤之间分化标志物表达的变化。
Am J Pathol. 1993 Jan;142(1):157-77.
2
Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.正常人类卵巢上皮向卵巢癌转变不同阶段的标志物谱。
Am J Pathol. 1991 Feb;138(2):455-63.
3
Differentiation margins of ovarian tumor pathology: first incidences of epithelial ovarian tumors monitored by marker antibodies.卵巢肿瘤病理学的分化边缘:通过标记抗体监测上皮性卵巢肿瘤的首次发病情况。
Cancer Detect Prev. 1997;21(3):247-57.
4
Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.癌胚蛋白磷脂酰肌醇蛋白聚糖-3可将卵黄囊瘤与卵巢透明细胞癌区分开来。
Am J Surg Pathol. 2008 Apr;32(4):600-7. doi: 10.1097/PAS.0b013e31815a565a.
5
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.性腺生殖细胞肿瘤:一篇选择性综述,重点强调鉴别诊断中的问题、新认识的问题及有争议的问题。
Mod Pathol. 2005 Feb;18 Suppl 2:S61-79. doi: 10.1038/modpathol.3800310.
6
Monoclonal antibody against human ovarian tumor-associated antigens.抗人卵巢肿瘤相关抗原的单克隆抗体。
J Natl Cancer Inst. 1986 May;76(5):781-91.
7
Immunocytochemical detection of ovarian carcinoma cells in serous effusions.浆液性积液中卵巢癌细胞的免疫细胞化学检测
Acta Cytol. 1993 May-Jun;37(3):272-9.
8
Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.单克隆抗体角蛋白7在腺癌鉴别诊断中的应用
Am J Pathol. 1990 Mar;136(3):641-55.
9
Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.人组织激肽释放酶4(KLK4)在浆液性卵巢癌中高表达。
Clin Cancer Res. 2001 Aug;7(8):2363-71.
10
Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.血小板源性生长因子及其受体在上皮性卵巢肿瘤中的表达及预后意义
Cancer Res. 1993 Oct 1;53(19):4550-4.

引用本文的文献

1
Relationship between immunohistochemical staining extent of CD47 and histopathologic features of bladder tumor.CD47免疫组化染色程度与膀胱肿瘤组织病理学特征之间的关系
Cent European J Urol. 2017;70(4):349-355. doi: 10.5173/ceju.2017.1357. Epub 2017 Oct 16.
2
The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition.微小RNA-200家族在卵巢癌中的作用:超越上皮-间质转化
Int J Mol Sci. 2017 Jun 6;18(6):1207. doi: 10.3390/ijms18061207.
3
Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells.

本文引用的文献

1
Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.针对人乳脂肪球膜上皮特异性成分的单克隆抗体:制备及其与培养细胞的反应
Int J Cancer. 1981 Jul 15;28(1):17-21. doi: 10.1002/ijc.2910280104.
2
Reactivity of a monoclonal antibody with human ovarian carcinoma.一种单克隆抗体与人卵巢癌的反应性。
J Clin Invest. 1981 Nov;68(5):1331-7. doi: 10.1172/jci110380.
3
Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview.
E-钙黏蛋白的缺失会破坏卵巢癌细胞中卵巢上皮包涵囊肿的形成以及集体细胞运动。
Oncotarget. 2016 Jan 26;7(4):4110-21. doi: 10.18632/oncotarget.6588.
4
Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47.针对无处不在的细胞表面受体 CD47 的治疗机会。
Expert Opin Ther Targets. 2013 Jan;17(1):89-103. doi: 10.1517/14728222.2013.733699. Epub 2012 Oct 27.
5
Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation.靶向CD47以调节组织对缺血和辐射的反应的治疗方法。
J Genet Syndr Gene Ther. 2011 Oct;2(2). doi: 10.4172/2157-7412.1000105. Epub 2011 Sep 26.
6
Programmed cell removal: a new obstacle in the road to developing cancer.程序性细胞清除:癌症研究道路上的新障碍。
Nat Rev Cancer. 2011 Dec 8;12(1):58-67. doi: 10.1038/nrc3171.
7
Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma.结直肠癌卵巢转移的临床病理和免疫组织化学特征。
World J Gastrointest Surg. 2010 Apr 27;2(4):109-16. doi: 10.4240/wjgs.v2.i4.109.
8
Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition.转化生长因子-β1、转化生长因子-β2和转化生长因子-β3通过诱导Smad3依赖的上皮-间质转化增强卵巢癌转移潜能。
Mol Cancer Res. 2008 May;6(5):695-705. doi: 10.1158/1541-7786.MCR-07-0294.
9
Differential gene expression in ovarian carcinoma: identification of potential biomarkers.卵巢癌中的差异基因表达:潜在生物标志物的鉴定
Am J Pathol. 2004 Aug;165(2):397-414. doi: 10.1016/S0002-9440(10)63306-8.
10
Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.卵巢原发性腺癌与结肠和乳腺来源的卵巢转移癌之间的免疫组织化学鉴别。统计学方法与直观方法的比较。
J Clin Pathol. 1999 Apr;52(4):283-90. doi: 10.1136/jcp.52.4.283.
免疫组织化学鉴定人类肿瘤中中间丝蛋白抗体:综述
Histochem J. 1983 Jul;15(7):691-713. doi: 10.1007/BF01002988.
4
Expression of intermediate filaments in normal ovaries and ovarian epithelial, sex cord-stromal, and germinal tumors.中间丝在正常卵巢及卵巢上皮性、性索间质和生殖细胞肿瘤中的表达
Int J Gynecol Pathol. 1983;2(1):64-71. doi: 10.1097/00004347-198301000-00006.
5
Cytokeratin and neurofilament in lung carcinomas.肺癌中的细胞角蛋白和神经丝蛋白。
Am J Pathol. 1984 Sep;116(3):363-9.
6
Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture.人间皮和间皮瘤在体内及培养环境中单纯上皮角蛋白与波形蛋白的共表达
Cancer Res. 1984 Jul;44(7):2991-9.
7
Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology.角蛋白丝单克隆抗体,对腺上皮及其肿瘤具有特异性。用于外科病理学。
Lab Invest. 1983 Sep;49(3):353-61.
8
Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture.间皮细胞中细胞骨架的调节:培养过程中快速生长期间角蛋白的可逆性丧失和波形蛋白的增加。
Cell. 1983 Aug;34(1):245-53. doi: 10.1016/0092-8674(83)90155-1.
9
Demonstration of keratin in human adenocarcinomas.人腺癌中角蛋白的显示
Am J Pathol. 1983 May;111(2):213-23.
10
Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology.通过中间丝分型进行肿瘤诊断:外科病理学的一种新工具。
Lab Invest. 1983 Apr;48(4):372-94.